Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents), By Test Location, By Technology (PCR, Sequencing, INAAT, TMA), By Application, By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 72 Business Hours
Molecular Diagnostics Market Growth & Trends
The global molecular diagnostics market size is expected to reach USD 31.9 billion by 2030, and is expected to decline at a CAGR of -1.6% from 2022 to 2030, according to a recent study by Grand View Research, Inc. The contraction in the market will be due to the decline in demand for molecular testing for COVID-19. However, factors such as the rising geriatric population and increasing demand for technologies such as NGS is expected to drive market growth.
Molecular diagnostics plays an important role in infectious disease testing as they can yield effective and fast results. Hence, the increasing prevalence of hospital-acquired infections & infectious diseases is projected to drive the market over the forecast period. Increasing incidence and awareness regarding genetic disorders is further anticipated to accelerate market growth. The miniaturization of three basic molecular assays-nanobiotechnology, biochips, and microfluidics are expected to increase the accuracy and specificity of diagnostic outcomes, and hence, increase the demand for molecular diagnostic products. These improvements are expected to enhance the availability of PoC molecular diagnostic tests to yield quick and effective test results.
Companies are expanding their product portfolios with the acquisition of smaller companies. For instance, in March 2021, Hologic announced the acquisition of Diagenode-a molecular diagnostic company with a wide range of PCR instruments, facilitating the detection of over 30 bacteria-for USD 159 million. Similarly, in April 2021, F. Hoffmann-La Roche Ltd. acquired GenMark Diagnostics, Inc. at a price of USD 24.05 per share in cash, and it holds around 82.89% of total shares of GenMark Diagnostics. GenMark Diagnostics, Inc. has proprietary technologies, such as eSensor XT-8 and ePlex, which can be utilized in developing tests for infectious diseases, including bloodstream infections.
Key players are enhancing their range of testing options for real-time PCR instruments by increasing R&D activities for the development of kits that target emerging diseases or by entering into agreements with other kit manufacturing companies. These include the introduction of Cobas HPV test assay in Cobas 4800 by Roche Diagnostics. The introduction of tuberculosis testing Xpert assay on GeneXpert platform by Cepheid is an example of such advancement. Such advances are anticipated to drive the global molecular diagnostics market.
Molecular Diagnostics Market Report Highlights
Molecular Diagnostics Market Growth & Trends
The global molecular diagnostics market size is expected to reach USD 31.9 billion by 2030, and is expected to decline at a CAGR of -1.6% from 2022 to 2030, according to a recent study by Grand View Research, Inc. The contraction in the market will be due to the decline in demand for molecular testing for COVID-19. However, factors such as the rising geriatric population and increasing demand for technologies such as NGS is expected to drive market growth.
Molecular diagnostics plays an important role in infectious disease testing as they can yield effective and fast results. Hence, the increasing prevalence of hospital-acquired infections & infectious diseases is projected to drive the market over the forecast period. Increasing incidence and awareness regarding genetic disorders is further anticipated to accelerate market growth. The miniaturization of three basic molecular assays-nanobiotechnology, biochips, and microfluidics are expected to increase the accuracy and specificity of diagnostic outcomes, and hence, increase the demand for molecular diagnostic products. These improvements are expected to enhance the availability of PoC molecular diagnostic tests to yield quick and effective test results.
Companies are expanding their product portfolios with the acquisition of smaller companies. For instance, in March 2021, Hologic announced the acquisition of Diagenode-a molecular diagnostic company with a wide range of PCR instruments, facilitating the detection of over 30 bacteria-for USD 159 million. Similarly, in April 2021, F. Hoffmann-La Roche Ltd. acquired GenMark Diagnostics, Inc. at a price of USD 24.05 per share in cash, and it holds around 82.89% of total shares of GenMark Diagnostics. GenMark Diagnostics, Inc. has proprietary technologies, such as eSensor XT-8 and ePlex, which can be utilized in developing tests for infectious diseases, including bloodstream infections.
Key players are enhancing their range of testing options for real-time PCR instruments by increasing R&D activities for the development of kits that target emerging diseases or by entering into agreements with other kit manufacturing companies. These include the introduction of Cobas HPV test assay in Cobas 4800 by Roche Diagnostics. The introduction of tuberculosis testing Xpert assay on GeneXpert platform by Cepheid is an example of such advancement. Such advances are anticipated to drive the global molecular diagnostics market.
Molecular Diagnostics Market Report Highlights
- Reagents dominated the overall market majorly driven by the high usage rate of reagents due to the COVID-19 pandemic
- PCR technology accounted for a revenue share of 64.6% in 2021. The increased use of PCR for the diagnosis of COVID-19 and other infectious diseases is one of the major reasons for its dominance
- Self-testing or OTC segment is anticipated to be the fastest-growing segment, over the forecast period, as it facilitates early diagnosis and constant patient monitoring. The launch of COVID-19 molecular self-tests is also expected to boost the growth of this segment.
- North America commanded the highest revenue share in 2021, driven by a high disease prevalence, proactive government measures, high testing rate for COVID-19, technological advancements, and improvements in healthcare infrastructure.
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Secondary Sources
1.3.3 Primary Research
1.3.4 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity flow approach
1.6.1.2 Approach 2: Country wise market estimation using bottom up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
1.12 List of Abbreviations
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Summary
CHAPTER 3 MOLECULAR DIAGNOSTICS MARKET VARIABLES, TRENDS & SCOPE
3.1 Molecular Diagnostics Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Regulatory and Reimbursement Framework
3.4 CLIA Waived Tests and Instruments
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.1.1 Increase in geriatric population
3.5.1.2 Introduction of technologically advanced products
3.5.1.3 Increase in demand for point-of-care facilities
3.5.1.4 Growing prevalence of target diseases
3.5.1.5 Increasing external funding for R&D
3.5.1.6 Outbreak of COVID-19
3.5.2 Market Restraint Analysis
3.5.2.1 Presence of ambiguous regulatory framework
3.5.2.2 High prices of molecular diagnostics tests
3.6 Molecular Diagnostics Market Analysis Tools
3.6.1 Porter’s Five Forces Analysis
3.6.2 SWOT Analysis; By factor (Political & Legal, Economic and Technological)
3.6.3 Major Deals & Strategic Alliances Analysis
3.6.3.1 New product launch
3.6.3.2 Mergers and acquisitions
3.6.3.3 Expansion
3.6.3.4 Partnerships
3.6.3.5 Marketing & promotions
3.6.3.6 Market entry strategies
CHAPTER 4 MOLECULAR DIAGNOSTICS MARKET - COMPETITIVE ANALYSIS
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.1.1 Company/Competition Categorization (Key innovators, Market leaders, Expansion)
4.1.2 Innovators
4.1.3 Key Differentiators
4.2 Vendor Landscape
4.2.1 List of key distributors
4.2.2 Key Company Market Share Analysis, 2021
4.2.2.1 Global company market share analysis, by Application, 2021
4.2.2.1.1 Global company market share analysis, Molecular diagnostics, Oncology, 2021
4.2.2.1.2 Global company market share analysis, Molecular diagnostics, Pharmacogenomics, 2021
4.2.2.1.3 Global company market share analysis, Molecular diagnostics, Infectious Diseases, 2021
4.2.2.1.4 Global company market share analysis, Molecular diagnostics, Genetic Testing, 2021
4.2.2.1.5 Global company market share analysis, Molecular diagnostics, Others (Neurological disease, Cardiovascular Diseases, Microbiology, Others) 2021
4.2.2.2 Global company market share analysis, by Technology, 2021
4.2.2.2.1 Global company market share analysis, Molecular diagnostics, Polymerase Chain Reaction, 2021
4.2.2.2.2 Global company market share analysis, Molecular diagnostics, In Situ Hybridization, 2021
4.2.2.2.3 Global company market share analysis, Molecular diagnostics, INAAT, 2021
4.2.2.2.4 Global company market share analysis, Molecular diagnostics, Chips & Microarrays, 2021
4.2.2.2.5 Global company market share analysis, Molecular diagnostics, Mass Spectrometry, 2021
4.2.2.2.6 Global company market share analysis, Molecular diagnostics, Sequencing, 2021
4.2.2.2.7 Global company market share analysis, Molecular diagnostics, Transcription Mediated Amplification, 2021
4.3 Public Companies
4.3.1 Company Market Position Analysis (2021)
4.3.2 Competitive Dashboard Analysis
4.4 Private Companies
4.4.1 List of Key Emerging Companies /Technology Disruptors/Innovators
4.4.2 Regional Network Map
4.4.3 Competitive Dashboard Analysis
CHAPTER 5 PRODUCT BUSINESS ANALYSIS
5.1 Molecular Diagnostics Market: Products Movement Analysis
5.1.1 Instruments
5.1.1.1 Instruments market estimates and forecast, 2017 - 2030 (USD Million)
5.1.2 Reagents
5.1.2.1 Reagents market estimates and forecast, 2017 - 2030 (USD Million)
5.1.3 Others
5.1.3.1 Others market estimates and forecast, 2017 - 2030 (USD Million)
CHAPTER 6 TEST LOCATION BUSINESS ANALYSIS
6.1 Molecular Diagnostics Market: Test Location Movement Analysis
6.1.1 Point-of-Care
6.1.1.1 Point-of-care market estimates and forecast, 2017 - 2030 (USD Million)
6.1.2 Self-testing or Over the Counter
6.1.2.1 Self-testing or over the counter market estimates and forecast, 2017 - 2030 (USD Million)
6.1.3 Central Laboratories
6.1.3.1 Central laboratories market estimates and forecast, 2017 - 2030 (USD Million)
CHAPTER 7 TECHNOLOGY BUSINESS ANALYSIS
7.1 Molecular Diagnostics Market: Technology Movement Analysis
7.1.1 Polymerase Chain Reaction (PCR)
7.1.1.1 Polymerase chain reaction market estimates and forecast, 2017 - 2030 (USD Million)
7.1.1.2 Nucleic acid extraction and purification
7.1.1.3 Nucleic Acid Extraction and purification market estimates and forecast, 2017 - 2030 (USD Million)
7.1.1.4 Others
7.1.1.5 Others market estimates and forecast, 2017 - 2030 (USD Million)
7.1.1.6 Polymerase chain reaction market, by Type
7.1.1.6.1 Multiplex PCR
7.1.1.6.1.1 Multiplex PCR market estimates and forecast, 2017 - 2030 (USD Million)
7.1.1.6.2 Other PCR
7.1.1.6.2.1 Other PCR market estimates and forecast, 2017 - 2030 (USD Million)
7.1.1.7 Polymerase chain reaction market, by Product
7.1.1.7.1 Instruments
7.1.1.7.1.1 Instruments PCR market estimates and forecast, 2017 - 2030 (USD Million)
7.1.1.7.2 Reagents
7.1.1.7.2.1 Reagents PCR market estimates and forecast, 2017 - 2030 (USD Million)
7.1.1.7.3 Others
7.1.1.7.3.1 Others PCR market estimates and forecast, 2017 - 2030 (USD Million)
7.1.2 In Situ Hybridization (ISH)
7.1.2.1 In Situ Hybridization market estimates and forecast, 2017 - 2030 (USD Million)
7.1.2.2 Instruments
7.1.2.2.1 Instruments ISH market estimates and forecast, 2017 - 2030 (USD Million)
7.1.2.3 Reagents
7.1.2.3.1 Reagents ISH market estimates and forecast, 2017 - 2030 (USD Million)
7.1.2.4 Others
7.1.2.4.1 Others ISH market estimates and forecast, 2017 - 2030 (USD Million)
7.1.3 INAAT
7.1.3.1 INAAT market estimates and forecast, 2017 - 2030 (USD Million)
7.1.3.2 Instruments
7.1.3.2.1 Instruments INAAT market estimates and forecast, 2017 - 2030 (USD Million)
7.1.3.3 Reagents
7.1.3.3.1 Reagents INAAT market estimates and forecast, 2017 - 2030 (USD Million)
7.1.3.4 Others
7.1.3.4.1 Others INAAT market estimates and forecast, 2017 - 2030 (USD Million)
7.1.4 Chips and Microarrays
7.1.4.1 Chips and Microarrays market estimates and forecast, 2017 - 2030 (USD Million)
7.1.4.2 Instruments
7.1.4.2.1 Instruments chips and microarrays market estimates and forecast, 2017 - 2030 (USD Million)
7.1.4.3 Reagents
7.1.4.3.1 Reagents chips and microarrays market estimates and forecast, 2017 - 2030 (USD Million)
7.1.4.4 Others
7.1.4.4.1 Others chips and microarrays market estimates and forecast, 2017 - 2030 (USD Million)
7.1.5 Mass Spectrometry
7.1.5.1 Mass Spectrometry market estimates and forecast, 2017 - 2030 (USD Million)
7.1.5.2 Instruments
7.1.5.2.1 Instruments mass spectrometry market estimates and forecast, 2017 - 2030 (USD Million)
7.1.5.3 Reagents
7.1.5.3.1 Reagents mass spectrometry market estimates and forecast, 2017 - 2030 (USD Million)
7.1.5.4 Others
7.1.5.4.1 Others mass spectrometry market estimates and forecast, 2017 - 2030 (USD Million)
7.1.6 Sequencing
7.1.6.1 Sequencing market estimates and forecast, 2017 - 2030 (USD Million)
7.1.6.2 Instruments
7.1.6.2.1 Instruments sequencing market estimates and forecast, 2017 - 2030 (USD Million)
7.1.6.3 Reagents
7.1.6.3.1 Reagents sequencing market estimates and forecast, 2017 - 2030 (USD Million)
7.1.6.4 Others
7.1.6.4.1 Others sequencing market estimates and forecast, 2017 - 2030 (USD Million)
7.1.7 Transcription Mediated Amplification (TMA)
7.1.7.1 Transcription mediated amplification market estimates and forecast, 2017 - 2030 (USD Million)
7.1.7.2 Instruments
7.1.7.2.1 Instruments TMA market estimates and forecast, 2017 - 2030 (USD Million)
7.1.7.3 Reagents
7.1.7.3.1 Reagents TMA market estimates and forecast, 2017 - 2030 (USD Million)
7.1.7.4 Others
7.1.7.4.1 Others TMA market estimates and forecast, 2017 - 2030 (USD Million)
7.1.8 Others
7.1.8.1 Others market estimates and forecast, 2017 - 2030 (USD Million)
7.1.8.2 Instruments
7.1.8.2.1 Instruments others market estimates and forecast, 2017 - 2030 (USD Million)
7.1.8.3 Reagents
7.1.8.3.1 Reagents others market estimates and forecast, 2017 - 2030 (USD Million)
7.1.8.4 Others
7.1.8.4.1 Others market estimates and forecast, 2017 - 2030 (USD Million)
CHAPTER 8 APPLICATION BUSINESS ANALYSIS
8.1 Molecular Diagnostics Market: Application Movement Analysis
8.1.1 Oncology
8.1.1.1 Oncology market estimates and forecast, 2017 - 2030 (USD Million)
8.1.1.2 Breast cancer
8.1.1.2.1 Breast cancer market estimates and forecast, 2017 - 2030 (USD Million)
8.1.1.3 Prostate cancer
8.1.1.3.1 Prostate cancer market estimates and forecast, 2017 - 2030 (USD Million)
8.1.1.4 Colorectal cancer
8.1.1.4.1 Colorectal cancer market estimates and forecast, 2017 - 2030 (USD Million)
8.1.1.5 Cervical cancer
8.1.1.5.1 Cervical cancer market estimates and forecast, 2017 - 2030 (USD Million)
8.1.1.6 Kidney cancer
8.1.1.6.1 Kidney cancer market estimates and forecast, 2017 - 2030 (USD Million)
8.1.1.7 Liver cancer
8.1.1.7.1 Liver cancer market estimates and forecast, 2017 - 2030 (USD Million)
8.1.1.8 Blood cancer
8.1.1.8.1 Blood cancer market estimates and forecast, 2017 - 2030 (USD Million)
8.1.1.9 Lung cancer
8.1.1.9.1 Lung cancer market estimates and forecast, 2017 - 2030 (USD Million)
8.1.1.10 Other cancers
8.1.1.10.1 Other cancer market estimates and forecast, 2017 - 2030 (USD Million)
8.1.2 Pharmacogenomics
8.1.2.1 Pharmacogenomics market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3 Infectious Diseases
8.1.3.1 Infectious Diseases market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.2 Methicillin-resistant Staphylococcus Aureus (MRSA)
8.1.3.2.1 MRSA market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.3 Clostridium difficile
8.1.3.3.1 Clostridium difficile market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.4 Vancomycin-Resistant Enterococci (VRE)
8.1.3.4.1 VRE market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.5 Carbapenem-resistant bacteria
8.1.3.5.1 Carbapenem-resistant bacteria market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.6 Flu
8.1.3.6.1 Flu market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.7 Respiratory Syncytial Virus (RSV)
8.1.3.7.1 RSV market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.8 Candida
8.1.3.8.1 Candida market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.9 Tuberculosis (TB) and drug-resistant TB
8.1.3.9.1 TB and drug-resistant TB market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.10 Meningitis
8.1.3.10.1 Meningitis market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.11 Gastrointestinal panel testing
8.1.3.11.1 Gastrointestinal panel testing market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.12 Chlamydia
8.1.3.12.1 Chlamydia market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.13 Gonorrhea
8.1.3.13.1 Gonorrhea market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.14 HIV
8.1.3.14.1 HIV market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.15 Hepatitis C
8.1.3.15.1 Hepatitis C market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.16 Hepatitis B
8.1.3.16.1 Hepatitis B market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.17 Other infectious disease market
8.1.3.17.1 Other infectious disease market estimates and forecast, 2017 - 2030 (USD Million)
8.1.4 Genetic Testing
8.1.4.1 Genetic testing market estimates and forecast, 2017 - 2030 (USD Million)
8.1.4.2 Newborn screening
8.1.4.2.1 Newborn screening market estimates and forecast, 2017 - 2030 (USD Million)
8.1.4.3 Predictive and presymptomatic testing
8.1.4.3.1 Predictive and presymptomatic testing market estimates and forecast, 2017 - 2030 (USD Million)
8.1.4.4 Other genetic testing
8.1.4.4.1 Other genetic testing market estimates and forecast, 2017 - 2030 (USD Million)
8.1.5 Neurological Diseases
8.1.5.1 Neurological diseases market estimates and forecast, 2017 - 2030 (USD Million)
8.1.6 Cardiovascular Diseases
8.1.6.1 Cardiovascular diseases market estimates and forecast, 2017 - 2030 (USD Million)
8.1.7 Microbiology
8.1.7.1 Microbiology market estimates and forecast, 2017 - 2030 (USD Million)
8.1.8 Others
8.1.8.1 Others market estimates and forecast, 2017 - 2030 (USD Million)
CHAPTER 9 REGIONAL BUSINESS ANALYSIS
9.1 Molecular Diagnostics Market: Regional Movement Analysis
9.1.1 North America
9.1.2 North America, SWOT Analysis
9.1.2.1 North America market estimates and forecast, 2017 - 2030 (USD Million)
9.1.2.2 U.S.
9.1.2.2.1 U.S. market estimates and forecast, 2017 - 2030 (USD Million)
9.1.2.3 Canada
9.1.2.3.1 Canada market estimates and forecast, 2017 - 2030 (USD Million)
9.1.3 Europe
9.1.4 Europe, SWOT Analysis
9.1.4.1 Europe market estimates and forecast, 2017 - 2030 (USD Million)
9.1.4.2 U.K.
9.1.4.2.1 U.K. market estimates and forecast, 2017 - 2030 (USD Million)
9.1.4.3 Germany
9.1.4.3.1 Germany market estimates and forecast, 2017 - 2030 (USD Million)
9.1.4.4 France
9.1.4.4.1 France market estimates and forecast, 2017 - 2030 (USD Million)
9.1.4.5 Spain
9.1.4.5.1 Spain market estimates and forecast, 2017 - 2030 (USD Million)
9.1.4.6 Italy
9.1.4.6.1 Italy market estimates and forecast, 2017 - 2030 (USD Million)
9.1.4.7 Belgium
9.1.4.7.1 Belgium market estimates and forecast, 2017 - 2030 (USD Million)
9.1.4.8 Switzerland
9.1.4.8.1 Switzerland market estimates and forecast, 2017 - 2030 (USD Million)
9.1.4.9 Netherlands
9.1.4.9.1 Netherlands market estimates and forecast, 2017 - 2030 (USD Million)
9.1.4.10 Poland
9.1.4.10.1 Poland market estimates and forecast, 2017 - 2030 (USD Million)
9.1.4.11 Austria
9.1.4.11.1 Austria market estimates and forecast, 2017 - 2030 (USD Million)
9.1.4.12 Greece
9.1.4.12.1 Greece market estimates and forecast, 2017 - 2030 (USD Million)
9.1.4.13 Sweden
9.1.4.13.1 Sweden market estimates and forecast, 2017 - 2030 (USD Million)
9.1.4.14 Turkey
9.1.4.14.1 Turkey market estimates and forecast, 2017 - 2030 (USD Million)
9.1.4.15 Finland
9.1.4.15.1 Finland market estimates and forecast, 2017 - 2030 (USD Million)
9.1.5 Asia Pacific
9.1.6 Asia Pacific, SWOT Analysis
9.1.6.1 Asia Pacific market estimates and forecast, 2017 - 2030 (USD Million)
9.1.6.2 Japan
9.1.6.2.1 Japan market estimates and forecast, 2017 - 2030 (USD Million)
9.1.6.3 China
9.1.6.3.1 China market estimates and forecast, 2017 - 2030 (USD Million)
9.1.6.4 India
9.1.6.4.1 India market estimates and forecast, 2017 - 2030 (USD Million)
9.1.6.5 Australia
9.1.6.5.1 Australia market estimates and forecast, 2017 - 2030 (USD Million)
9.1.6.6 New Zealand
9.1.6.6.1 New Zealand market estimates and forecast, 2017 - 2030 (USD Million)
9.1.6.7 Sri Lanka
9.1.6.7.1 Sri Lanka market estimates and forecast, 2017 - 2030 (USD Million)
9.1.6.8 Malaysia
9.1.6.8.1 Malaysia market estimates and forecast, 2017 - 2030 (USD Million)
9.1.6.9 Thailand
9.1.6.9.1 Thailand market estimates and forecast, 2017 - 2030 (USD Million)
9.1.6.10 Vietnam
9.1.6.10.1 Vietnam market estimates and forecast, 2017 - 2030 (USD Million)
9.1.6.11 Singapore
9.1.6.11.1 Singapore market estimates and forecast, 2017 - 2030 (USD Million)
9.1.7 Latin America
9.1.8 Latin America, SWOT Analysis
9.1.8.1 Latin America market estimates and forecast, 2017 - 2030 (USD Million)
9.1.8.2 Brazil
9.1.8.2.1 Brazil market estimates and forecast, 2017 - 2030 (USD Million)
9.1.8.3 Mexico
9.1.8.3.1 Mexico market estimates and forecast, 2017 - 2030 (USD Million)
9.1.8.4 Colombia
9.1.8.4.1 Colombia market estimates and forecast, 2017 - 2030 (USD Million)
9.1.8.5 Chile
9.1.8.5.1 Chile market estimates and forecast, 2017 - 2030 (USD Million)
9.1.8.6 Peru
9.1.8.6.1 Peru market estimates and forecast, 2017 - 2030 (USD Million)
9.1.8.7 Argentina
9.1.8.7.1 Argentina market estimates and forecast, 2017 - 2030 (USD Million)
9.1.9 Middle East & Africa
9.1.10 Middle East & Africa, SWOT Analysis
9.1.11 Middle East & Africa market estimates and forecast, 2017 - 2030 (USD Million)
9.1.11.1 South Africa
9.1.11.1.1 South Africa market estimates and forecast, 2017 - 2030 (USD Million)
9.1.11.2 Saudi Arabia
9.1.11.2.1 Saudi Arabia market estimates and forecast, 2017 - 2030 (USD Million)
9.1.11.3 Jordan
9.1.11.3.1 Jordan market estimates and forecast, 2017 - 2030 (USD Million)
9.1.11.4 United Arab Emirates
9.1.11.4.1 United Arab Emirates market estimates and forecast, 2017 - 2030 (USD Million)
9.1.11.5 Qatar
9.1.11.5.1 Qatar market estimates and forecast, 2017 - 2030 (USD Million)
9.1.11.6 Nigeria
9.1.11.6.1 Nigeria market estimates and forecast, 2017 - 2030 (USD Million)
9.1.11.7 Egypt
9.1.11.7.1 Egypt market estimates and forecast, 2017 - 2030 (USD Million)
CHAPTER 10 COMPANY PROFILE
10.1 Market Participation Categorization
10.2 Company Profiles
10.2.1 Abbott
10.2.1.1 Company overview
10.2.1.2 Alere, Inc.
10.2.1.3 Financial performance
10.2.1.4 Product benchmarking
10.2.1.5 Strategic initiatives
10.2.2 Becton, Dickinson and Company
10.2.2.1 Company overview
10.2.2.2 Financial performance
10.2.2.3 Product benchmarking
10.2.2.4 Strategic initiatives
10.2.3 bioM?rieux SA
10.2.3.1 Company overview
10.2.3.2 Financial performance
10.2.3.3 Product benchmarking
10.2.3.4 Strategic initiatives
10.2.4 Bio-Rad Laboratories, Inc.
10.2.4.1 Company overview
10.2.4.2 Financial performance
10.2.4.3 Product benchmarking
10.2.4.4 Strategic initiatives
10.2.5 Agilent Technologies, Inc.
10.2.5.1 Company overview
10.2.5.2 Financial performance
10.2.5.3 Product benchmarking
10.2.5.4 Strategic initiatives
10.2.6 Danaher Corporation
10.2.6.1 Company overview
10.2.6.2 Cepheid
10.2.6.3 Beckman Coulter
10.2.6.4 Leica Biosystems
10.2.6.5 Financial performance
10.2.6.6 Product benchmarking
10.2.6.7 Strategic initiatives
10.2.6.8 Strategic initiatives of Cepheid
10.2.6.9 Strategic initiatives of Beckman Coulter, Inc.
10.2.6.10 Strategic initiatives of Leica Biosystems
10.2.7 Hologic, Inc. (Gen Probe)
10.2.7.1 Company overview
10.2.7.2 Financial performance
10.2.7.3 Product benchmarking
10.2.7.4 Strategic initiatives
10.2.8 Illumina, Inc.
10.2.8.1 Company overview
10.2.8.2 Financial performance
10.2.8.3 Product benchmarking
10.2.8.4 Strategic initiatives
10.2.9 Johnson & Johnson Services, Inc.
10.2.9.1 Company overview
10.2.9.2 Financial performance
10.2.9.3 Product benchmarking
10.2.9.4 Strategic initiatives
10.2.10 GRIFOLs S.A.
10.2.10.1 Company overview
10.2.10.2 Financial performance
10.2.10.3 Product benchmarking
10.2.10.4 Strategic initiatives
10.2.11 Qiagen
10.2.11.1 Company overview
10.2.11.2 Financial performance
10.2.11.3 Product benchmarking
10.2.11.4 Strategic initiatives
10.2.12 F. Hoffmann-La Roche Ltd
10.2.12.1 Company overview
10.2.12.2 Financial performance
10.2.12.3 Product benchmarking
10.2.12.4 Strategic initiatives
10.2.13 Siemens Healtineers
10.2.13.1 Company overview
10.2.13.2 Financial performance
10.2.13.3 Product benchmarking
10.2.13.4 Strategic initiatives
10.2.14 Sysmex Corporation
10.2.14.1 Company overview
10.2.14.2 Financial performance
10.2.14.3 Product benchmarking
10.2.14.4 Strategic initiatives
1.1 Market Segmentation
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Secondary Sources
1.3.3 Primary Research
1.3.4 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity flow approach
1.6.1.2 Approach 2: Country wise market estimation using bottom up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
1.12 List of Abbreviations
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Summary
CHAPTER 3 MOLECULAR DIAGNOSTICS MARKET VARIABLES, TRENDS & SCOPE
3.1 Molecular Diagnostics Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Regulatory and Reimbursement Framework
3.4 CLIA Waived Tests and Instruments
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.1.1 Increase in geriatric population
3.5.1.2 Introduction of technologically advanced products
3.5.1.3 Increase in demand for point-of-care facilities
3.5.1.4 Growing prevalence of target diseases
3.5.1.5 Increasing external funding for R&D
3.5.1.6 Outbreak of COVID-19
3.5.2 Market Restraint Analysis
3.5.2.1 Presence of ambiguous regulatory framework
3.5.2.2 High prices of molecular diagnostics tests
3.6 Molecular Diagnostics Market Analysis Tools
3.6.1 Porter’s Five Forces Analysis
3.6.2 SWOT Analysis; By factor (Political & Legal, Economic and Technological)
3.6.3 Major Deals & Strategic Alliances Analysis
3.6.3.1 New product launch
3.6.3.2 Mergers and acquisitions
3.6.3.3 Expansion
3.6.3.4 Partnerships
3.6.3.5 Marketing & promotions
3.6.3.6 Market entry strategies
CHAPTER 4 MOLECULAR DIAGNOSTICS MARKET - COMPETITIVE ANALYSIS
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.1.1 Company/Competition Categorization (Key innovators, Market leaders, Expansion)
4.1.2 Innovators
4.1.3 Key Differentiators
4.2 Vendor Landscape
4.2.1 List of key distributors
4.2.2 Key Company Market Share Analysis, 2021
4.2.2.1 Global company market share analysis, by Application, 2021
4.2.2.1.1 Global company market share analysis, Molecular diagnostics, Oncology, 2021
4.2.2.1.2 Global company market share analysis, Molecular diagnostics, Pharmacogenomics, 2021
4.2.2.1.3 Global company market share analysis, Molecular diagnostics, Infectious Diseases, 2021
4.2.2.1.4 Global company market share analysis, Molecular diagnostics, Genetic Testing, 2021
4.2.2.1.5 Global company market share analysis, Molecular diagnostics, Others (Neurological disease, Cardiovascular Diseases, Microbiology, Others) 2021
4.2.2.2 Global company market share analysis, by Technology, 2021
4.2.2.2.1 Global company market share analysis, Molecular diagnostics, Polymerase Chain Reaction, 2021
4.2.2.2.2 Global company market share analysis, Molecular diagnostics, In Situ Hybridization, 2021
4.2.2.2.3 Global company market share analysis, Molecular diagnostics, INAAT, 2021
4.2.2.2.4 Global company market share analysis, Molecular diagnostics, Chips & Microarrays, 2021
4.2.2.2.5 Global company market share analysis, Molecular diagnostics, Mass Spectrometry, 2021
4.2.2.2.6 Global company market share analysis, Molecular diagnostics, Sequencing, 2021
4.2.2.2.7 Global company market share analysis, Molecular diagnostics, Transcription Mediated Amplification, 2021
4.3 Public Companies
4.3.1 Company Market Position Analysis (2021)
4.3.2 Competitive Dashboard Analysis
4.4 Private Companies
4.4.1 List of Key Emerging Companies /Technology Disruptors/Innovators
4.4.2 Regional Network Map
4.4.3 Competitive Dashboard Analysis
CHAPTER 5 PRODUCT BUSINESS ANALYSIS
5.1 Molecular Diagnostics Market: Products Movement Analysis
5.1.1 Instruments
5.1.1.1 Instruments market estimates and forecast, 2017 - 2030 (USD Million)
5.1.2 Reagents
5.1.2.1 Reagents market estimates and forecast, 2017 - 2030 (USD Million)
5.1.3 Others
5.1.3.1 Others market estimates and forecast, 2017 - 2030 (USD Million)
CHAPTER 6 TEST LOCATION BUSINESS ANALYSIS
6.1 Molecular Diagnostics Market: Test Location Movement Analysis
6.1.1 Point-of-Care
6.1.1.1 Point-of-care market estimates and forecast, 2017 - 2030 (USD Million)
6.1.2 Self-testing or Over the Counter
6.1.2.1 Self-testing or over the counter market estimates and forecast, 2017 - 2030 (USD Million)
6.1.3 Central Laboratories
6.1.3.1 Central laboratories market estimates and forecast, 2017 - 2030 (USD Million)
CHAPTER 7 TECHNOLOGY BUSINESS ANALYSIS
7.1 Molecular Diagnostics Market: Technology Movement Analysis
7.1.1 Polymerase Chain Reaction (PCR)
7.1.1.1 Polymerase chain reaction market estimates and forecast, 2017 - 2030 (USD Million)
7.1.1.2 Nucleic acid extraction and purification
7.1.1.3 Nucleic Acid Extraction and purification market estimates and forecast, 2017 - 2030 (USD Million)
7.1.1.4 Others
7.1.1.5 Others market estimates and forecast, 2017 - 2030 (USD Million)
7.1.1.6 Polymerase chain reaction market, by Type
7.1.1.6.1 Multiplex PCR
7.1.1.6.1.1 Multiplex PCR market estimates and forecast, 2017 - 2030 (USD Million)
7.1.1.6.2 Other PCR
7.1.1.6.2.1 Other PCR market estimates and forecast, 2017 - 2030 (USD Million)
7.1.1.7 Polymerase chain reaction market, by Product
7.1.1.7.1 Instruments
7.1.1.7.1.1 Instruments PCR market estimates and forecast, 2017 - 2030 (USD Million)
7.1.1.7.2 Reagents
7.1.1.7.2.1 Reagents PCR market estimates and forecast, 2017 - 2030 (USD Million)
7.1.1.7.3 Others
7.1.1.7.3.1 Others PCR market estimates and forecast, 2017 - 2030 (USD Million)
7.1.2 In Situ Hybridization (ISH)
7.1.2.1 In Situ Hybridization market estimates and forecast, 2017 - 2030 (USD Million)
7.1.2.2 Instruments
7.1.2.2.1 Instruments ISH market estimates and forecast, 2017 - 2030 (USD Million)
7.1.2.3 Reagents
7.1.2.3.1 Reagents ISH market estimates and forecast, 2017 - 2030 (USD Million)
7.1.2.4 Others
7.1.2.4.1 Others ISH market estimates and forecast, 2017 - 2030 (USD Million)
7.1.3 INAAT
7.1.3.1 INAAT market estimates and forecast, 2017 - 2030 (USD Million)
7.1.3.2 Instruments
7.1.3.2.1 Instruments INAAT market estimates and forecast, 2017 - 2030 (USD Million)
7.1.3.3 Reagents
7.1.3.3.1 Reagents INAAT market estimates and forecast, 2017 - 2030 (USD Million)
7.1.3.4 Others
7.1.3.4.1 Others INAAT market estimates and forecast, 2017 - 2030 (USD Million)
7.1.4 Chips and Microarrays
7.1.4.1 Chips and Microarrays market estimates and forecast, 2017 - 2030 (USD Million)
7.1.4.2 Instruments
7.1.4.2.1 Instruments chips and microarrays market estimates and forecast, 2017 - 2030 (USD Million)
7.1.4.3 Reagents
7.1.4.3.1 Reagents chips and microarrays market estimates and forecast, 2017 - 2030 (USD Million)
7.1.4.4 Others
7.1.4.4.1 Others chips and microarrays market estimates and forecast, 2017 - 2030 (USD Million)
7.1.5 Mass Spectrometry
7.1.5.1 Mass Spectrometry market estimates and forecast, 2017 - 2030 (USD Million)
7.1.5.2 Instruments
7.1.5.2.1 Instruments mass spectrometry market estimates and forecast, 2017 - 2030 (USD Million)
7.1.5.3 Reagents
7.1.5.3.1 Reagents mass spectrometry market estimates and forecast, 2017 - 2030 (USD Million)
7.1.5.4 Others
7.1.5.4.1 Others mass spectrometry market estimates and forecast, 2017 - 2030 (USD Million)
7.1.6 Sequencing
7.1.6.1 Sequencing market estimates and forecast, 2017 - 2030 (USD Million)
7.1.6.2 Instruments
7.1.6.2.1 Instruments sequencing market estimates and forecast, 2017 - 2030 (USD Million)
7.1.6.3 Reagents
7.1.6.3.1 Reagents sequencing market estimates and forecast, 2017 - 2030 (USD Million)
7.1.6.4 Others
7.1.6.4.1 Others sequencing market estimates and forecast, 2017 - 2030 (USD Million)
7.1.7 Transcription Mediated Amplification (TMA)
7.1.7.1 Transcription mediated amplification market estimates and forecast, 2017 - 2030 (USD Million)
7.1.7.2 Instruments
7.1.7.2.1 Instruments TMA market estimates and forecast, 2017 - 2030 (USD Million)
7.1.7.3 Reagents
7.1.7.3.1 Reagents TMA market estimates and forecast, 2017 - 2030 (USD Million)
7.1.7.4 Others
7.1.7.4.1 Others TMA market estimates and forecast, 2017 - 2030 (USD Million)
7.1.8 Others
7.1.8.1 Others market estimates and forecast, 2017 - 2030 (USD Million)
7.1.8.2 Instruments
7.1.8.2.1 Instruments others market estimates and forecast, 2017 - 2030 (USD Million)
7.1.8.3 Reagents
7.1.8.3.1 Reagents others market estimates and forecast, 2017 - 2030 (USD Million)
7.1.8.4 Others
7.1.8.4.1 Others market estimates and forecast, 2017 - 2030 (USD Million)
CHAPTER 8 APPLICATION BUSINESS ANALYSIS
8.1 Molecular Diagnostics Market: Application Movement Analysis
8.1.1 Oncology
8.1.1.1 Oncology market estimates and forecast, 2017 - 2030 (USD Million)
8.1.1.2 Breast cancer
8.1.1.2.1 Breast cancer market estimates and forecast, 2017 - 2030 (USD Million)
8.1.1.3 Prostate cancer
8.1.1.3.1 Prostate cancer market estimates and forecast, 2017 - 2030 (USD Million)
8.1.1.4 Colorectal cancer
8.1.1.4.1 Colorectal cancer market estimates and forecast, 2017 - 2030 (USD Million)
8.1.1.5 Cervical cancer
8.1.1.5.1 Cervical cancer market estimates and forecast, 2017 - 2030 (USD Million)
8.1.1.6 Kidney cancer
8.1.1.6.1 Kidney cancer market estimates and forecast, 2017 - 2030 (USD Million)
8.1.1.7 Liver cancer
8.1.1.7.1 Liver cancer market estimates and forecast, 2017 - 2030 (USD Million)
8.1.1.8 Blood cancer
8.1.1.8.1 Blood cancer market estimates and forecast, 2017 - 2030 (USD Million)
8.1.1.9 Lung cancer
8.1.1.9.1 Lung cancer market estimates and forecast, 2017 - 2030 (USD Million)
8.1.1.10 Other cancers
8.1.1.10.1 Other cancer market estimates and forecast, 2017 - 2030 (USD Million)
8.1.2 Pharmacogenomics
8.1.2.1 Pharmacogenomics market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3 Infectious Diseases
8.1.3.1 Infectious Diseases market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.2 Methicillin-resistant Staphylococcus Aureus (MRSA)
8.1.3.2.1 MRSA market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.3 Clostridium difficile
8.1.3.3.1 Clostridium difficile market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.4 Vancomycin-Resistant Enterococci (VRE)
8.1.3.4.1 VRE market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.5 Carbapenem-resistant bacteria
8.1.3.5.1 Carbapenem-resistant bacteria market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.6 Flu
8.1.3.6.1 Flu market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.7 Respiratory Syncytial Virus (RSV)
8.1.3.7.1 RSV market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.8 Candida
8.1.3.8.1 Candida market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.9 Tuberculosis (TB) and drug-resistant TB
8.1.3.9.1 TB and drug-resistant TB market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.10 Meningitis
8.1.3.10.1 Meningitis market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.11 Gastrointestinal panel testing
8.1.3.11.1 Gastrointestinal panel testing market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.12 Chlamydia
8.1.3.12.1 Chlamydia market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.13 Gonorrhea
8.1.3.13.1 Gonorrhea market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.14 HIV
8.1.3.14.1 HIV market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.15 Hepatitis C
8.1.3.15.1 Hepatitis C market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.16 Hepatitis B
8.1.3.16.1 Hepatitis B market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.17 Other infectious disease market
8.1.3.17.1 Other infectious disease market estimates and forecast, 2017 - 2030 (USD Million)
8.1.4 Genetic Testing
8.1.4.1 Genetic testing market estimates and forecast, 2017 - 2030 (USD Million)
8.1.4.2 Newborn screening
8.1.4.2.1 Newborn screening market estimates and forecast, 2017 - 2030 (USD Million)
8.1.4.3 Predictive and presymptomatic testing
8.1.4.3.1 Predictive and presymptomatic testing market estimates and forecast, 2017 - 2030 (USD Million)
8.1.4.4 Other genetic testing
8.1.4.4.1 Other genetic testing market estimates and forecast, 2017 - 2030 (USD Million)
8.1.5 Neurological Diseases
8.1.5.1 Neurological diseases market estimates and forecast, 2017 - 2030 (USD Million)
8.1.6 Cardiovascular Diseases
8.1.6.1 Cardiovascular diseases market estimates and forecast, 2017 - 2030 (USD Million)
8.1.7 Microbiology
8.1.7.1 Microbiology market estimates and forecast, 2017 - 2030 (USD Million)
8.1.8 Others
8.1.8.1 Others market estimates and forecast, 2017 - 2030 (USD Million)
CHAPTER 9 REGIONAL BUSINESS ANALYSIS
9.1 Molecular Diagnostics Market: Regional Movement Analysis
9.1.1 North America
9.1.2 North America, SWOT Analysis
9.1.2.1 North America market estimates and forecast, 2017 - 2030 (USD Million)
9.1.2.2 U.S.
9.1.2.2.1 U.S. market estimates and forecast, 2017 - 2030 (USD Million)
9.1.2.3 Canada
9.1.2.3.1 Canada market estimates and forecast, 2017 - 2030 (USD Million)
9.1.3 Europe
9.1.4 Europe, SWOT Analysis
9.1.4.1 Europe market estimates and forecast, 2017 - 2030 (USD Million)
9.1.4.2 U.K.
9.1.4.2.1 U.K. market estimates and forecast, 2017 - 2030 (USD Million)
9.1.4.3 Germany
9.1.4.3.1 Germany market estimates and forecast, 2017 - 2030 (USD Million)
9.1.4.4 France
9.1.4.4.1 France market estimates and forecast, 2017 - 2030 (USD Million)
9.1.4.5 Spain
9.1.4.5.1 Spain market estimates and forecast, 2017 - 2030 (USD Million)
9.1.4.6 Italy
9.1.4.6.1 Italy market estimates and forecast, 2017 - 2030 (USD Million)
9.1.4.7 Belgium
9.1.4.7.1 Belgium market estimates and forecast, 2017 - 2030 (USD Million)
9.1.4.8 Switzerland
9.1.4.8.1 Switzerland market estimates and forecast, 2017 - 2030 (USD Million)
9.1.4.9 Netherlands
9.1.4.9.1 Netherlands market estimates and forecast, 2017 - 2030 (USD Million)
9.1.4.10 Poland
9.1.4.10.1 Poland market estimates and forecast, 2017 - 2030 (USD Million)
9.1.4.11 Austria
9.1.4.11.1 Austria market estimates and forecast, 2017 - 2030 (USD Million)
9.1.4.12 Greece
9.1.4.12.1 Greece market estimates and forecast, 2017 - 2030 (USD Million)
9.1.4.13 Sweden
9.1.4.13.1 Sweden market estimates and forecast, 2017 - 2030 (USD Million)
9.1.4.14 Turkey
9.1.4.14.1 Turkey market estimates and forecast, 2017 - 2030 (USD Million)
9.1.4.15 Finland
9.1.4.15.1 Finland market estimates and forecast, 2017 - 2030 (USD Million)
9.1.5 Asia Pacific
9.1.6 Asia Pacific, SWOT Analysis
9.1.6.1 Asia Pacific market estimates and forecast, 2017 - 2030 (USD Million)
9.1.6.2 Japan
9.1.6.2.1 Japan market estimates and forecast, 2017 - 2030 (USD Million)
9.1.6.3 China
9.1.6.3.1 China market estimates and forecast, 2017 - 2030 (USD Million)
9.1.6.4 India
9.1.6.4.1 India market estimates and forecast, 2017 - 2030 (USD Million)
9.1.6.5 Australia
9.1.6.5.1 Australia market estimates and forecast, 2017 - 2030 (USD Million)
9.1.6.6 New Zealand
9.1.6.6.1 New Zealand market estimates and forecast, 2017 - 2030 (USD Million)
9.1.6.7 Sri Lanka
9.1.6.7.1 Sri Lanka market estimates and forecast, 2017 - 2030 (USD Million)
9.1.6.8 Malaysia
9.1.6.8.1 Malaysia market estimates and forecast, 2017 - 2030 (USD Million)
9.1.6.9 Thailand
9.1.6.9.1 Thailand market estimates and forecast, 2017 - 2030 (USD Million)
9.1.6.10 Vietnam
9.1.6.10.1 Vietnam market estimates and forecast, 2017 - 2030 (USD Million)
9.1.6.11 Singapore
9.1.6.11.1 Singapore market estimates and forecast, 2017 - 2030 (USD Million)
9.1.7 Latin America
9.1.8 Latin America, SWOT Analysis
9.1.8.1 Latin America market estimates and forecast, 2017 - 2030 (USD Million)
9.1.8.2 Brazil
9.1.8.2.1 Brazil market estimates and forecast, 2017 - 2030 (USD Million)
9.1.8.3 Mexico
9.1.8.3.1 Mexico market estimates and forecast, 2017 - 2030 (USD Million)
9.1.8.4 Colombia
9.1.8.4.1 Colombia market estimates and forecast, 2017 - 2030 (USD Million)
9.1.8.5 Chile
9.1.8.5.1 Chile market estimates and forecast, 2017 - 2030 (USD Million)
9.1.8.6 Peru
9.1.8.6.1 Peru market estimates and forecast, 2017 - 2030 (USD Million)
9.1.8.7 Argentina
9.1.8.7.1 Argentina market estimates and forecast, 2017 - 2030 (USD Million)
9.1.9 Middle East & Africa
9.1.10 Middle East & Africa, SWOT Analysis
9.1.11 Middle East & Africa market estimates and forecast, 2017 - 2030 (USD Million)
9.1.11.1 South Africa
9.1.11.1.1 South Africa market estimates and forecast, 2017 - 2030 (USD Million)
9.1.11.2 Saudi Arabia
9.1.11.2.1 Saudi Arabia market estimates and forecast, 2017 - 2030 (USD Million)
9.1.11.3 Jordan
9.1.11.3.1 Jordan market estimates and forecast, 2017 - 2030 (USD Million)
9.1.11.4 United Arab Emirates
9.1.11.4.1 United Arab Emirates market estimates and forecast, 2017 - 2030 (USD Million)
9.1.11.5 Qatar
9.1.11.5.1 Qatar market estimates and forecast, 2017 - 2030 (USD Million)
9.1.11.6 Nigeria
9.1.11.6.1 Nigeria market estimates and forecast, 2017 - 2030 (USD Million)
9.1.11.7 Egypt
9.1.11.7.1 Egypt market estimates and forecast, 2017 - 2030 (USD Million)
CHAPTER 10 COMPANY PROFILE
10.1 Market Participation Categorization
10.2 Company Profiles
10.2.1 Abbott
10.2.1.1 Company overview
10.2.1.2 Alere, Inc.
10.2.1.3 Financial performance
10.2.1.4 Product benchmarking
10.2.1.5 Strategic initiatives
10.2.2 Becton, Dickinson and Company
10.2.2.1 Company overview
10.2.2.2 Financial performance
10.2.2.3 Product benchmarking
10.2.2.4 Strategic initiatives
10.2.3 bioM?rieux SA
10.2.3.1 Company overview
10.2.3.2 Financial performance
10.2.3.3 Product benchmarking
10.2.3.4 Strategic initiatives
10.2.4 Bio-Rad Laboratories, Inc.
10.2.4.1 Company overview
10.2.4.2 Financial performance
10.2.4.3 Product benchmarking
10.2.4.4 Strategic initiatives
10.2.5 Agilent Technologies, Inc.
10.2.5.1 Company overview
10.2.5.2 Financial performance
10.2.5.3 Product benchmarking
10.2.5.4 Strategic initiatives
10.2.6 Danaher Corporation
10.2.6.1 Company overview
10.2.6.2 Cepheid
10.2.6.3 Beckman Coulter
10.2.6.4 Leica Biosystems
10.2.6.5 Financial performance
10.2.6.6 Product benchmarking
10.2.6.7 Strategic initiatives
10.2.6.8 Strategic initiatives of Cepheid
10.2.6.9 Strategic initiatives of Beckman Coulter, Inc.
10.2.6.10 Strategic initiatives of Leica Biosystems
10.2.7 Hologic, Inc. (Gen Probe)
10.2.7.1 Company overview
10.2.7.2 Financial performance
10.2.7.3 Product benchmarking
10.2.7.4 Strategic initiatives
10.2.8 Illumina, Inc.
10.2.8.1 Company overview
10.2.8.2 Financial performance
10.2.8.3 Product benchmarking
10.2.8.4 Strategic initiatives
10.2.9 Johnson & Johnson Services, Inc.
10.2.9.1 Company overview
10.2.9.2 Financial performance
10.2.9.3 Product benchmarking
10.2.9.4 Strategic initiatives
10.2.10 GRIFOLs S.A.
10.2.10.1 Company overview
10.2.10.2 Financial performance
10.2.10.3 Product benchmarking
10.2.10.4 Strategic initiatives
10.2.11 Qiagen
10.2.11.1 Company overview
10.2.11.2 Financial performance
10.2.11.3 Product benchmarking
10.2.11.4 Strategic initiatives
10.2.12 F. Hoffmann-La Roche Ltd
10.2.12.1 Company overview
10.2.12.2 Financial performance
10.2.12.3 Product benchmarking
10.2.12.4 Strategic initiatives
10.2.13 Siemens Healtineers
10.2.13.1 Company overview
10.2.13.2 Financial performance
10.2.13.3 Product benchmarking
10.2.13.4 Strategic initiatives
10.2.14 Sysmex Corporation
10.2.14.1 Company overview
10.2.14.2 Financial performance
10.2.14.3 Product benchmarking
10.2.14.4 Strategic initiatives
LIST OF TABLES
TABLE 1 Country share estimation
TABLE 2 North America molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 3 North America molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 4 North America molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 5 North America PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 6 North America PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 7 North America ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 8 North America INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 9 North America chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 10 North America mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 11 North America sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 12 North America TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 13 North America others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 14 North America molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 15 North America molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 16 North America molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 17 North America molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 18 U.S. molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 19 U.S. molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 20 U.S. molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 21 U.S. PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 22 U.S. PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 23 U.S. ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 24 U.S. INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 25 U.S. chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 26 U.S. mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 27 U.S. sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 28 U.S. TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 29 U.S. others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 30 U.S. molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 31 U.S. molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 32 U.S. molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 33 U.S. molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 34 Canada molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 35 Canada molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 36 Canada molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 37 Canada PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 38 Canada PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 39 Canada ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 40 Canada INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 41 Canada chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 42 Canada mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 43 Canada sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 44 Canada TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 45 Canada others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 46 Canada molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 47 Canada molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 48 Canada molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 49 Canada molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 50 Europe molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 51 Europe molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 52 Europe molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 53 Europe PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 54 Europe PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 55 Europe ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 56 Europe INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 57 Europe chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 58 Europe mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 59 Europe sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 60 Europe TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 61 Europe others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 62 Europe molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 63 Europe molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 64 Europe molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 65 Europe molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 66 U.K. molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 67 U.K. molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 68 U.K. molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 69 U.K. PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 70 U.K. PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 71 U.K. ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 72 U.K. INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 73 U.K. chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 74 U.K. mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 75 U.K. sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 76 U.K. TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 77 U.K. others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 78 U.K. molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 79 U.K. molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 80 U.K. molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 81 U.K. molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 82 Germany molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 83 Germany molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 84 Germany molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 85 Germany PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 86 Germany PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 87 Germany ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 88 Germany INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 89 Germany chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 90 Germany mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 91 Germany sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 92 Germany TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 93 Germany others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 94 Germany molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 95 Germany molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 96 Germany molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 97 Germany molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 98 France molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 99 France molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 100 France molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 101 France PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 102 France PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 103 France ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 104 France INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 105 France chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 106 France mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 107 France sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 108 France TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 109 France others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 110 France molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 111 France molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 112 France molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 113 France molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 114 Spain molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 115 Spain molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 116 Spain molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 117 Spain PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 118 Spain PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 119 Spain ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 120 Spain INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 121 Spain chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 122 Spain mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 123 Spain sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 124 Spain TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 125 Spain others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 126 Spain molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 127 Spain molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 128 Spain molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 129 Spain molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 130 Italy molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 131 Italy molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 132 Italy molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 133 Italy PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 134 Italy PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 135 Italy ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 136 Italy INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 137 Italy chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 138 Italy mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 139 Italy sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 140 Italy TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 141 Italy others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 142 Italy molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 143 Italy molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 144 Italy molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 145 Italy molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 146 Belgium molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 147 Belgium molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 148 Belgium molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 149 Belgium PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 150 Belgium PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 151 Belgium ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 152 Belgium INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 153 Belgium chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 154 Belgium mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 155 Belgium sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 156 Belgium TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 157 Belgium others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 158 Belgium molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 159 Belgium molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 160 Belgium molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 161 Belgium molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 162 Switzerland molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 163 Switzerland molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 164 Switzerland molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 165 Switzerland PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 166 Switzerland PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 167 Switzerland ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 168 Switzerland INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 169 Switzerland chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 170 Switzerland mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 171 Switzerland sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 172 Switzerland TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 173 Switzerland others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 174 Switzerland molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 175 Switzerland molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 176 Switzerland molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 177 Switzerland molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 178 Netherlands molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 179 Netherlands molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 180 Netherlands molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 181 Netherlands PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 182 Netherlands PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 183 Netherlands ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 184 Netherlands INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 185 Netherlands chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 186 Netherlands mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 187 Netherlands sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 188 Netherlands TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 189 Netherlands others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 190 Netherlands molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 191 Netherlands molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 192 Netherlands molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 193 Netherlands molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 194 Poland molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 195 Poland molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 196 Poland molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 197 Poland PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 198 Poland PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 199 Poland ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 200 Poland INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 201 Poland chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 202 Poland mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 203 Poland sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 204 Poland TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 205 Poland others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 206 Poland molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 207 Poland molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 208 Poland molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 209 Poland molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 210 Austria molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 211 Austria molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 212 Austria molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 213 Austria PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 214 Austria PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 215 Austria ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 216 Austria INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 217 Austria chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 218 Austria mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 219 Austria sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 220 Austria TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 221 Austria others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 222 Austria molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 223 Austria molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 224 Austria molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 225 Austria molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 226 Greece molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 227 Greece molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 228 Greece molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 229 Greece PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 230 Greece PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 231 Greece ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 232 Greece INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 233 Greece chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 234 Greece mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 235 Greece sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 236 Greece TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 237 Greece others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 238 Greece molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 239 Greece molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 240 Greece molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 241 Greece molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 242 Sweden molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 243 Sweden molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 244 Sweden molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 245 Sweden PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 246 Sweden PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 247 Sweden ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 248 Sweden INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 249 Sweden chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 250 Sweden mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 251 Sweden sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 252 Sweden TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 253 Sweden others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 254 Sweden molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 255 Sweden molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 256 Sweden molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 257 Sweden molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 258 Turkey molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 259 Turkey molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 260 Turkey molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 261 Turkey PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 262 Turkey PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 263 Turkey ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 264 Turkey INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 265 Turkey chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 266 Turkey mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 267 Turkey sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 268 Turkey TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 269 Turkey others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 270 Turkey molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 271 Turkey molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 272 Turkey molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 273 Turkey molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 274 Finland molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 275 Finland molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 276 Finland molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 277 Finland PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 278 Finland PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 279 Finland ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 280 Finland INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 281 Finland chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 282 Finland mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 283 Finland sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 284 Finland TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 285 Finland others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 286 Finland molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 287 Finland molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 288 Finland molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 289 Finland molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 290 Asia Pacific molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 291 Asia Pacific molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 292 Asia Pacific molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 293 Asia Pacific PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 294 Asia Pacific PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 295 Asia Pacific ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 296 Asia Pacific INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 297 Asia Pacific chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 298 Asia Pacific mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 299 Asia Pacific sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 300 Asia Pacific TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 1 Country share estimation
TABLE 2 North America molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 3 North America molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 4 North America molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 5 North America PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 6 North America PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 7 North America ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 8 North America INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 9 North America chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 10 North America mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 11 North America sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 12 North America TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 13 North America others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 14 North America molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 15 North America molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 16 North America molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 17 North America molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 18 U.S. molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 19 U.S. molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 20 U.S. molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 21 U.S. PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 22 U.S. PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 23 U.S. ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 24 U.S. INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 25 U.S. chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 26 U.S. mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 27 U.S. sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 28 U.S. TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 29 U.S. others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 30 U.S. molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 31 U.S. molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 32 U.S. molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 33 U.S. molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 34 Canada molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 35 Canada molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 36 Canada molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 37 Canada PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 38 Canada PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 39 Canada ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 40 Canada INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 41 Canada chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 42 Canada mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 43 Canada sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 44 Canada TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 45 Canada others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 46 Canada molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 47 Canada molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 48 Canada molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 49 Canada molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 50 Europe molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 51 Europe molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 52 Europe molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 53 Europe PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 54 Europe PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 55 Europe ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 56 Europe INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 57 Europe chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 58 Europe mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 59 Europe sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 60 Europe TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 61 Europe others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 62 Europe molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 63 Europe molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 64 Europe molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 65 Europe molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 66 U.K. molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 67 U.K. molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 68 U.K. molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 69 U.K. PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 70 U.K. PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 71 U.K. ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 72 U.K. INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 73 U.K. chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 74 U.K. mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 75 U.K. sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 76 U.K. TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 77 U.K. others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 78 U.K. molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 79 U.K. molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 80 U.K. molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 81 U.K. molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 82 Germany molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 83 Germany molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 84 Germany molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 85 Germany PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 86 Germany PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 87 Germany ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 88 Germany INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 89 Germany chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 90 Germany mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 91 Germany sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 92 Germany TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 93 Germany others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 94 Germany molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 95 Germany molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 96 Germany molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 97 Germany molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 98 France molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 99 France molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 100 France molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 101 France PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 102 France PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 103 France ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 104 France INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 105 France chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 106 France mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 107 France sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 108 France TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 109 France others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 110 France molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 111 France molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 112 France molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 113 France molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 114 Spain molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 115 Spain molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 116 Spain molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 117 Spain PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 118 Spain PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 119 Spain ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 120 Spain INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 121 Spain chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 122 Spain mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 123 Spain sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 124 Spain TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 125 Spain others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 126 Spain molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 127 Spain molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 128 Spain molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 129 Spain molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 130 Italy molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 131 Italy molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 132 Italy molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 133 Italy PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 134 Italy PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 135 Italy ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 136 Italy INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 137 Italy chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 138 Italy mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 139 Italy sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 140 Italy TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 141 Italy others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 142 Italy molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 143 Italy molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 144 Italy molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 145 Italy molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 146 Belgium molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 147 Belgium molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 148 Belgium molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 149 Belgium PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 150 Belgium PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 151 Belgium ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 152 Belgium INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 153 Belgium chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 154 Belgium mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 155 Belgium sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 156 Belgium TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 157 Belgium others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 158 Belgium molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 159 Belgium molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 160 Belgium molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 161 Belgium molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 162 Switzerland molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 163 Switzerland molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 164 Switzerland molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 165 Switzerland PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 166 Switzerland PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 167 Switzerland ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 168 Switzerland INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 169 Switzerland chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 170 Switzerland mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 171 Switzerland sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 172 Switzerland TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 173 Switzerland others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 174 Switzerland molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 175 Switzerland molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 176 Switzerland molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 177 Switzerland molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 178 Netherlands molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 179 Netherlands molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 180 Netherlands molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 181 Netherlands PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 182 Netherlands PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 183 Netherlands ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 184 Netherlands INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 185 Netherlands chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 186 Netherlands mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 187 Netherlands sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 188 Netherlands TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 189 Netherlands others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 190 Netherlands molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 191 Netherlands molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 192 Netherlands molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 193 Netherlands molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 194 Poland molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 195 Poland molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 196 Poland molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 197 Poland PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 198 Poland PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 199 Poland ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 200 Poland INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 201 Poland chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 202 Poland mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 203 Poland sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 204 Poland TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 205 Poland others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 206 Poland molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 207 Poland molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 208 Poland molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 209 Poland molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 210 Austria molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 211 Austria molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 212 Austria molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 213 Austria PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 214 Austria PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 215 Austria ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 216 Austria INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 217 Austria chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 218 Austria mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 219 Austria sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 220 Austria TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 221 Austria others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 222 Austria molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 223 Austria molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 224 Austria molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 225 Austria molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 226 Greece molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 227 Greece molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 228 Greece molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 229 Greece PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 230 Greece PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 231 Greece ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 232 Greece INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 233 Greece chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 234 Greece mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 235 Greece sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 236 Greece TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 237 Greece others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 238 Greece molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 239 Greece molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 240 Greece molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 241 Greece molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 242 Sweden molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 243 Sweden molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 244 Sweden molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 245 Sweden PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 246 Sweden PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 247 Sweden ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 248 Sweden INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 249 Sweden chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 250 Sweden mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 251 Sweden sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 252 Sweden TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 253 Sweden others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 254 Sweden molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 255 Sweden molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 256 Sweden molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 257 Sweden molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 258 Turkey molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 259 Turkey molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 260 Turkey molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 261 Turkey PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 262 Turkey PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 263 Turkey ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 264 Turkey INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 265 Turkey chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 266 Turkey mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 267 Turkey sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 268 Turkey TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 269 Turkey others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 270 Turkey molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 271 Turkey molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 272 Turkey molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 273 Turkey molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 274 Finland molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 275 Finland molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 276 Finland molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 277 Finland PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 278 Finland PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 279 Finland ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 280 Finland INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 281 Finland chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 282 Finland mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 283 Finland sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 284 Finland TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 285 Finland others technology market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 286 Finland molecular diagnostics market estimates and forecasts, by application, 2017 - 2030 (USD Million)
TABLE 287 Finland molecular diagnostics market estimates and forecasts, by oncology, 2017 - 2030 (USD Million)
TABLE 288 Finland molecular diagnostics market estimates and forecasts, by infectious diseases, 2017 - 2030 (USD Million)
TABLE 289 Finland molecular diagnostics market estimates and forecasts, by genetic testing, 2017 - 2030 (USD Million)
TABLE 290 Asia Pacific molecular diagnostics market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 291 Asia Pacific molecular diagnostics market estimates and forecasts, by test location, 2017 - 2030 (USD Million)
TABLE 292 Asia Pacific molecular diagnostics market estimates and forecasts, by technology, 2017 - 2030 (USD Million)
TABLE 293 Asia Pacific PCR market estimates and forecasts, by type, 2017 - 2030 (USD Million)
TABLE 294 Asia Pacific PCR market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 295 Asia Pacific ISH market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 296 Asia Pacific INAAT market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 297 Asia Pacific chips and microarrays market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 298 Asia Pacific mass spectrometry market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 299 Asia Pacific sequencing market estimates and forecasts, by product, 2017 - 2030 (USD Million)
TABLE 300 Asia Pacific TMA market estimates and forecasts, by product, 2017 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Molecular diagnostics market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Molecular diagnostics market snapshot
Fig. 10 Parent market outlook
Fig. 11 Penetration & growth prospect mapping
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Global population by age group, 2017, 2021, & 2030
Fig. 14 General trend shifts from laboratory to point-of-care
Fig. 15 Market restrain relevance analysis (Current & future impact)
Fig. 16 Porter’s five forces analysis
Fig. 17 SWOT analysis, by factor (Political & legal, economic and technological)
Fig. 18 Strategy mapping
Fig. 19 Competition categorization
Fig. 20 Company market share analysis - Molecular diagnostics market, 2021
Fig. 21 Company market share analysis - Molecular diag
Fig. 1 Molecular diagnostics market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Molecular diagnostics market snapshot
Fig. 10 Parent market outlook
Fig. 11 Penetration & growth prospect mapping
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Global population by age group, 2017, 2021, & 2030
Fig. 14 General trend shifts from laboratory to point-of-care
Fig. 15 Market restrain relevance analysis (Current & future impact)
Fig. 16 Porter’s five forces analysis
Fig. 17 SWOT analysis, by factor (Political & legal, economic and technological)
Fig. 18 Strategy mapping
Fig. 19 Competition categorization
Fig. 20 Company market share analysis - Molecular diagnostics market, 2021
Fig. 21 Company market share analysis - Molecular diag
